➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Moodys
McKinsey
Merck
McKesson

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Insulin aspart recombinant - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for insulin aspart recombinant

Identify potential brand extensions & biosimilar entrants

SponsorPhase
University Hospital, Strasbourg, FrancePhase 4
Yale UniversityEarly Phase 1
McGill UniversityN/A

See all insulin aspart recombinant clinical trials

Recent Litigation for insulin aspart recombinant

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
NOVO NORDISK INC. v. SANDOZ INC.2020-06-04
SANOFI-AVENTIS U.S. LLC v. MYLAN N v.2017-10-24
Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.2017-03-03

See all insulin aspart recombinant litigation

PTAB Litigation
PetitionerDate
2014-01-23

See all insulin aspart recombinant litigation

Patent Text Search: US Patents for insulin aspart recombinant

These patents were identified by searching patent claims

Supplementary Protection Certificates for insulin aspart recombinant

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
13C/038 Belgium   Start Trial PRODUCT NAME: RYZODEG-INSULINE DEGLUDEC/INSULINE ASPARTE; AUTHORISATION NUMBER AND DATE: EU/1/12/806/001 20130121
2005 00046 Denmark   Start Trial PRODUCT NAME: OPLOSELIGT INSULIN ASPART / PROTAMINKRYSTALLERET INSULIN ASPART 100E/ML I FORHOLDET 50/50
2005 00047 Denmark   Start Trial PRODUCT NAME: INSULIN ASPART, PROTAMINKRYSTALLISERET
13/34 Ireland   Start Trial PRODUCT: INSULIN DEGLUDEC IN ALL ITS FORMS AS THEY ARE PROTECTED BY THE BASIC PATENTS; REGISTRATION NO/DATE: IRELAND EU/1/12/807-001, 004, 005, 007-009, 012, 013 AND 015 / 21/01/2013
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Johnson and Johnson
Merck
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.